Saturday, September 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 10, 2026

Shopify Eyes 18% Upside After Sharp 2026 Selloff

View original at finance.yahoo.com
“Free cash flow came in at $715 million with a 19% margin.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • AI commerce tools including Catalog, Sidekick, and Universal Commerce Protocol could meaningfully lift merchant attach rates over two to three years

    60% confidence
  • The 38% discount to 52-week high presents opportunity given intact operational momentum and early-stage monetization potential in AI commerce tools and cross-border expansion

    60% confidence
  • Bulls see potential for stock to reach $183 and higher based on compounding growth across multiple vectors

    60% confidence
  • Recommendation is BUY with 90% confidence level

    60% confidence
  • Shopify shares have 17.68% upside potential with price target of $132.25 from current price of $112.38

    60% confidence

Data points we hold from this source

Shopify Inc. · one month return-13.13 percent
Shopify Inc. · ytd return-30.19 percent
Shopify Inc. · price target132.25 USD
Shopify Inc. · operating income growth35.7 percent
Shopify Inc. · country presence175 countries
Shopify Inc. · free cash flow margin19 percent
Shopify Inc. · b2b gmv growth96 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com